14,936
Total Claims
$2.3M
Drug Cost
1,286
Beneficiaries
$1,820
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+19%
Cost per patient vs peers
$1,820 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 12,465 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 691 | $604K |
| Sacubitril/Valsartan | 441 | $485K |
| Rivaroxaban | 499 | $463K |
| Empagliflozin | 192 | $193K |
| Evolocumab | 121 | $107K |
| Alirocumab | 111 | $90K |
| Dapagliflozin Propanediol | 37 | $33K |
| Evolocumab | 43 | $33K |
| Dronedarone Hcl | 20 | $30K |
| Ticagrelor | 27 | $25K |
| Ranolazine | 95 | $20K |
| Atorvastatin Calcium | 1,328 | $16K |
| Clopidogrel Bisulfate | 1,071 | $14K |
| Pitavastatin Calcium | 15 | $14K |
| Ivabradine Hcl | 11 | $13K |
Prescribing Profile
77
Unique Drugs
$1.8M
Patient Profile
74
Avg Age
52%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data